Sequoia Capital India has invested $12 million in over-the-counter drug and cosmetic maker Paras Pharmaceuticals, bringing the Indian company’s total raised to $54 million in just the past two months, according to VentureWire (sub required).

In October, U.K.-based Actis Capital made a $42 million commitment to Paras citing a current boon in the pharmaceuticals industry in India and strong product placement of at least two of Para’s 15 brands. Based in Ahmedabad, India, Paras sells pharmaceutical and cosmeceutical products….